EXPOSURE-RESPONSE MODELING OF THE ACR20 SCORE IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH CERTOLIZUMAB PEGOL

40

  • Ucroix, B.
  • Lovem, M.
  • Stockis, A.
  • Sargenlini-Maier, M. L.
  • Karlsson, M. O.
  • Friberg, L. E.

  • 1Pharmacometrics, UCB Pharma SA, Braine-L Alleud, Belgium; 2Div. of Pharmacokinctics and Drug Therapy, Uppsala University, Uppsala, Sweden.

The Journal of Clinical Pharmacology 48(9):p 1107, September 2008.
Copyright © 2008 American College of Clinical Pharmacology